66163-67-5

Basic information

• Product Name: [1-Carbamoyl-2-(4-nitro-phenyl)-ethyl]-carbamic acid tert-butyl ester
• Synonyms: [1-Carbamoyl-2-(4-nitro-phenyl)-ethyl]-carbamic acid tert-butyl ester
• CAS NO: 66163-67-5
• Molecular Weight: 309.322
• Mol File: 66163-67-5.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: [1-Carbamoyl-2-(4-nitro-phenyl)-ethyl]-carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [1-Carbamoyl-2-(4-nitro-phenyl)-ethyl]-carbamic acid tert-butyl ester(66163-67-5)
• EPA Substance Registry System: [1-Carbamoyl-2-(4-nitro-phenyl)-ethyl]-carbamic acid tert-butyl ester(66163-67-5)

Safety Data

• Hazardous Substances Data: 66163-67-5(Hazardous Substances Data)

Upstream product

• 33305-77-0 Boc-Phe(p-NO₂)-OH 
• 1991-83-9 4-nitrophenylalanine 
• 63-91-2 L-phenylalanine 
• 86937-80-6 2-tert-butoxycarbonylamino-3-(4-nitro-phenyl)-propionic acid 
• 66163-66-4 2-tert-Butoxycarbonylamino-3-(4-nitro-phenyl)-propionic acid 4-nitro-phenyl ester 

Downstream Products

• 360569-98-8 [2-(4-nitrophenyl)-1-(S)-thiocarbamoylethyl]carbamic acid tert-butyl ester 
• 81677-61-4 (2S)-2-amino-3-(4-nitrophenyl)propanamide 
• 1000611-92-6 4-{(S)-2-(4-ethylthiazol-2-yl)-2-[(S)-2-(methoxycarbonylamino)-3-phenylpropanamido]ethyl}phenylsulfamic acid 
• 1185320-68-6 C₁₇H₁₅N₃O₂S 
• 1000611-42-6 4-{(S)-2-[(S)-2-(tert-butoxycarbonylamino)-3-methylbutanamido]-2-(4-ethylthiazol-2-yl)ethyl}phenylsulfamic acid ammonium salt 
• 1000611-51-7 [1-(S)-(phenylthiazol-2-yl)-2-(4-sulfoaminophenyl)ethyl]carbamic acid tert-butyl ester ammonium salt 
• 1000611-88-0 [2-(4-nitrophenyl)-1-(S)-(4-phenylthiazol-2-yl)ethyl]-carbamic acid tert-butyl ester 
• 1000611-87-9 tert-butyl N-[(1S)-1-{[(1S)-1-(4-ethyl-1,3-thiazol-2-yl)-2-(4-nitrophenyl)ethyl]carbamoyl}-2-methylpropyl]carbamate 
• 1000611-39-1 4-[(S)-2-((S)-2-acetamido-3-phenylpropanamido)-2-(4-ethylthiazol-2-yl)ethyl]phenylsulfamic acid ammonium salt 
• 1000611-86-8 (S)-2-acetamido-N-[(S)-1-(4-ethylthiazol-2-yl)-2-(4-nitrophenyl)-ethyl]-3-phenylpropanamide 
• 1235336-46-5 N-{4-[(2S)-2-(4-ethyl-1,3-oxazol-2-yl)-2-(2-phenylacetamido)ethyl]phenyl}sulfamic acid ammonium salt 
• 1000395-41-4 N-[1-(4-ethyloxazol-2-yl)-2-(4-nitrophenyl)ethyl]-2-phenylacetamide 
• 1000610-92-3 4-{(S)-2-[(S)-2-(tert-butoxycarbonylamino)-3-phenylpropanamido]-2-(4-ethylthiazol-2-yl)ethyl}phenylsulfamic acid ammonium salt 
• 1000611-81-3 {1-[1-(4-ethylthiazol-2-yl)-2-(4-nitrophenyl)ethylcarbamoyl]-2-phenylethyl}carbamic acid tert-butyl ester 

Relevant articles and documents

THIADIAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF OCULAR EDEMA

Disclosed are methods for the treatment of diseases or conditions of the eye, especially retinopathies, ocular edema and ocular neovascularization. Non-limiting examples of these diseases or conditions include diabetic macular edema, age-related macular d

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. Formulations for increased solubility ar

METHODS FOR TREATING VASCULAR LEAK SYNDROME

Disclosed are methods for treating Vascular Leak Syndrome. Further disclosed are methods for treating vascular leakage due to inflammatory diseases, inter alia, sepsis, lupus, irritable bowel disease. Yet further disclosed are methods for treating renal c